19th Jan 2005 12:54
Medical Solutions PLC19 January 2005 Not for release, distribution or publication in or into the US, Canada, Ireland,Australia, South Africa or Japan 19 January 2005 MEDICAL SOLUTIONS PLC Board Changes and details of share capital On 22 December 2004, the Company announced that it was undertaking a Placing andOpen Offer, conditional upon which Andy Longstaffe would step down as FinanceDirector and Company Secretary, Dr Neil Johnston would join the Board as ChiefFinancial Officer and Company Secretary, and Robin Slinger would join the Boardas a Non-executive Director. The Placing and Open Offer became whollyunconditional today and, consequently, these board changes became effective asof today. Following completion of the Placing and Open Offer, the Company also announcesthat, under Rule 2.10 of the City Code on Takeover and Mergers, it now has199,779,075 new ordinary shares of 2 pence each in issue. Further new ordinaryshares will be allotted by the Company in due course as consideration forcertain previous acquisitions, details of which are set out in the Company'sprospectus dated 22 December 2004. Further announcements in accordance with Rule2.10 will be made at the appropriate time. The International SecuritiesIdentification Number for such ordinary shares is GB0009739649. For further information please contact: Bell PottingerAnn-marie Wilkinson/Geoff Callow Tel: 020 7861 3232 Nomura International plc is acting exclusively for Medical Solutions in relationto the Placing and the Open Offer and is not advising any other person ortreating any other person as its client in relation thereto, and will not beresponsible to any person other than Medical Solutions for providing theprotections afforded to its clients nor for providing advice in relation to thePlacing or the Open Offer. Charles Stanley & Company Limited is acting exclusively for Medical Solutions inrelation to the Placing and is not advising any other person or treating anyother person as its client in relation thereto, and will not be responsible toany person other than Medical Solutions for providing the protections affordedto its clients nor for providing advice in relation to the Placing. The Directors of Medical Solutions accept responsibility for the informationcontained in this announcement. To the best of the knowledge and belief of theDirectors (who have taken all reasonable care to ensure that such is the case)the information contained in this announcement is in accordance with the factsand does not omit anything likely to affect the import of such information. This announcement does not constitute or form part of any offer or invitation tosell or issue, or the solicitation of any offer to subscribe for, the newordinary shares in any jurisdiction in which such offer or solicitation isunlawful. The new ordinary shares have not been, and will not be, registeredunder the US Securities Act of 1933 (as amended), under the securities laws ofany state of the US or under the applicable securities laws of Canada, Ireland,Australia, South Africa or Japan. Accordingly, unless an exemption under anyapplicable law is available, the New Ordinary Shares may not be offered, sold,transferred, taken up or delivered, directly or indirectly, in the US, Canada,Ireland, Australia, South Africa or Japan or any other country outside theUnited Kingdom where such distribution may lead to a breach of any legal orregulatory requirement. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SBS.L